Latest news

New research released today by Global Justice Now examines the history of some of the leading corporations producing coronavirus medicines, warning that their business model is likely to make controlling the pandemic more difficult, despite the rapid production of vaccines.

Thirty seven MSPs, from across the parties, have written to the UK government ahead of an important international meeting to call on them to support a proposal to make Covid-19 vaccines and treatments affordable to all countries, not just the richest.

Nearly 70 poor countries will only be able to vaccinate one in ten people against Covid-19 next year unless urgent action is taken by governments and the pharmaceutical industry to make sure enough doses are produced, a group of campaigning organisations warned today, as the UK begins to rollout vaccinations.

Amendment puts in place a modern framework for democratic oversight of trade negotiations suited for the 21st century.


Reaction to the cuts to the UK aid budget, announced by the Chancellor today.

In response to the news that the Oxford University vaccine shows 70% protection, Heidi Chow, pharmaceuticals campaigner at Global Justice Now said: 
“These results are good news, but with so much government funding for this vaccine, it is time Oxford University’s deal with pharma giant AstraZeneca was made public. Individual parts have been leaked to the media, but the deal itself has been kept secret, so we don’t know the legal framework for making the vaccine available to the world.  

Just 12% of the global population stand to receive the majority of doses from a vaccine that has received billions in public funding

Reacting to today's announcement of the G20's Common Framework for debt treatments, Daniel Willis, campaign manager at Global Justice Now said:

"Covid-19 has left many countries around the world in a debtors' prison. Today rather than setting them free, the G20 have offered an hour of exercise and a bowl of thin gruel. If anything it will extend the sentence.

Over 80% of vaccine doses bought by governments with only 14% of global population

Commenting on what Joe Biden's victory means for the US-UK trade deal, Nick Dearden, director of Global Justice Now said:

“Trump’s defeat is a major setback for Boris Johnson, but this is not the end of chlorinated chicken. 

Reacting to reports that early phase 3 trials of Pfizer's Covid-19 vaccine have been 90% successful, Heidi Chow, pharmaceuticals campaigner at Global Justice Now said: 

“It’s positive news that Pfizer may have found an effective Covid-19 vaccine, but right now it will only be for the few. We need governments to step in and make it available for the many – including by suspending patent rights.  

Events have taken place around the UK today to protest against the government’s proposed trade deal with the United States. It comes ten days ahead of the US Presidential election and follows the fifth round of negotiations over the deal, which took place this week.